Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 63014Erstellt: 3. November 2026

trans-Tramadol hydrochloride

k-315 · cg315 · TRAMODOL HCL · AURORA KA-863 · Tramadol Impurity 5 · CIS-TRAMADOL HYDROCHLORIDE · TraMadol Hydrochloride, EP · O-DESMETHYL-CIS-TRAMADOL HCL

https://huagongshe.com/de/chemical/63014

Molekülstruktur von trans-Tramadol hydrochloride

Identifikatoren & physikalische Daten

CAS No.73806-49-2
SummenformelC16H26ClNO2
Durchschnittliche Molmasse299,83 g/mol
Monoisotopische Masse299,1652068 g/mol
SMILESCOc1cccc([C@@]2(O)CCCC[C@H]2CN(C)C)c1.Cl
InChIKeyPPKXEPBICJTCRU-DMLYUBSXSA-N
PubChem CID63014
EC No.641-583-7
DTXSIDDTXSID60224225

Chemische & physikalische Eigenschaften

Polarare Oberfläche (TPSA)32,7
H-Brücken-Donoren2
H-Brücken-Akzeptoren3
Frei drehbare Bindungen4
Schwere Atome20
Formalladung0
Komplexität282
Lagerbedingungen-10 to -25°C
Hauptanwendungenpharmaceutical
InChI1S/C16H25NO2.ClH/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H31H/t14-,16-/m0./s1
InChIKeyPPKXEPBICJTCRU-DMLYUBSXSA-N
SMILES[Cl-].N(C[C@H]1[C@@](CCCC1)(O)c2cc(ccc2)OC)(C)C.[H+]

Sicherheit & Vorschriften

GHS-EinstufungDangerH301 (66.7%): Toxic if swallowed [Danger Acute toxicity, oral]P264, P270, P273, P301+P316, P301+P317, P321, P330, P391, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 3 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Regulatorische Informationentrans-Tramadol hydrochloride: Does not have an individual approval but may be used under an appropriate group standard
Hazard Classes and CategoriesAcute Tox. 3 (66.7%)
Wassergefährdungsklasse (WGK)WGK 3
Zollcode2922504500
Lagerklasse6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
GefahrenklasseAcute Tox. 3 Oral

Anwendungen & Verwendung

Verwenden

A Tramadol(T712500) impurity classified as an analgesic. Used in the preparation of analogs which can potentially be used in the treatment of opiate receptor-mediated disorder.